Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
Open Access
- 1 January 2002
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 2 (1) , 48-56
- https://doi.org/10.1034/j.1600-6143.2002.020109.x
Abstract
Acute graft rejection remains a major problem in renal transplant recipients, and there is no consensus on the optimal immunosuppressive strategy. Immunoprophylaxis with Thymoglobulin® or basiliximab...Keywords
This publication has 26 references indexed in Scilit:
- DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1Transplantation, 2000
- Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipientsThe Lancet, 1997
- Immunosuppressants: Cellular and molecular mechanisms of actionAmerican Journal of Kidney Diseases, 1996
- Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipientsTransplant International, 1996
- Muromonab CD3Drugs, 1996
- PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1995
- ANALYSES OF THE UNOS SCIENTIFIC RENAL TRANSPLANT REGISTRY AT THREE YEARS—EARLY EVENTS AFFECTING TRANSPLANT SUCCESS1–3Transplantation, 1992
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- A COMPARISON OF THE EFFECTS OF CYCLOSPORINE VERSUS ANTILYMPHOCYTE GLOBULIN ON DELAYED GRAFT FUNCTION IN CADAVER RENAL TRANSPLANT RECIPIENTSTransplantation, 1989
- INDIVIDUALIZATION OF IMMEDIATE POSTTRANSPLANT IMMUNOSUPPRESSIONTransplantation, 1988